Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia.

ABSTRACT:

SUBMITTER: Delgado J 

PROVIDER: S-EPMC6746038 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature